Zymergen
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.0m | Seed | ||
$44.0m | Series A | ||
$130m | Series B | ||
* | $400m | Series C | |
$100m | Debt | ||
$300m Valuation: $2.0b | Series D | ||
N/A | $500m Valuation: $3.5b | IPO | |
* | $300m Valuation: $300m | Acquisition | |
Total Funding | CAD1.2b |
Recent News about Zymergen
EditZymergen is a pioneering science material innovation company that leverages biology to create groundbreaking products across various industries. By partnering with nature, Zymergen develops biofabricated materials that are used in electronics, agriculture, personal care, and more. The company operates in the advanced materials market, focusing on sustainable and innovative solutions that redefine how products are made and what they are made of. Zymergen's business model includes both ready-to-use solutions and collaborative projects with major companies, ensuring next-generation innovation inspired by nature and built by biology. Revenue is generated through the sale of these advanced materials and through partnerships with other industry leaders.
Keywords: biofabrication, advanced materials, electronics, agriculture, personal care, sustainability, innovation, biology, partnerships, next-generation